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Bruno et al. (2017) presented an interesting study 
on the genetic variants of β-casofensin, a bioactive 
peptide corresponding to bovine β-casein A2 f94–123, 
with promising effects on intestinal health (Plaisancié 
et al., 2013, 2015). However, we have to underline that 
A1 variant differs from A2 by only a single amino acid 
(Pro67 in A
2 vs. His67 in A
1). This substitution is re-
sponsible for the scientific and commercial debate on 
“A2 milk,” which involves different genetic variants 
(Caroli et al., 2009).
Thus, no difference exists between the A2 and A1 
variants within the β-casofensin sequence. The nomen-
clature on milk protein variants is precise and updated, 
based on a wide literature on the subject. Reviews 
are available on milk protein variant nomenclature, 
sequences, and effects (e.g., Formaggioni et al., 1999; 
Farrell et al., 2004; Caroli et al., 2009). Bruno et al. 
(2017) refer to a substitution Glu117 versus Gln117 oc-
curring in variants A1 and G. This substitution was 
described by Lebrun et al. (1995) in a proteomic study 
carried out on commercial casein but was not referred 
to as a genetic variant. Senocq et al. (2002) reported 
a substitution from Glu to Gln within the f114–169 
sequence. This variant, which also differs from A2 by 2 
residues at positions 72 and 93, was named H2 (Farrell 
et al., 2004).
Within β-casofensin, genetic differences in A3 (resi-
due 106) and B (residue 122) variants were properly 
accounted for by Bruno et al. (2017). Another inter-
esting variant to be investigated is β-casein I, which 
differs from A2 by a Met93 to Leu93 substitution (Caroli 
et al., 2009). An intriguing question could be whether 
the cleavage site that results in β-casofensin could be 
affected by this exchange.
In conclusion, the genetic polymorphism of bovine 
β-casein remains an open matter. Further efforts occur 
to understand and exploit it better without forgetting 
the existing nomenclature.
REFERENCES
Bruno, J., A. Nicolas, S. Pesenti, J. Schwarz, J. L. Simon, J. Léonil, 
and P. Plaisancié. 2017. Variants of β-casofensin, a bioactive milk 
peptide, differently modulate the intestinal barrier: In vivo and ex 
vivo studies in rats. J. Dairy Sci. 100:3360–3372. https:// doi .org/ 
10 .3168/ jds .2016 -12067.
Caroli, A. M., S. Chessa, and G. J. Erhardt. 2009. Invited review: Milk 
protein polymorphisms in cattle: Effect on animal breeding and 
human nutrition. J. Dairy Sci. 92:5335–5352. https:// doi .org/ 10 
.3168/ jds .2009 -2461.
Farrell, H. M., Jr., R. Jimenez-Flores, G. T. Bleck, E. M. Brown, J. E. 
Butler, L. K. Creamer, C. L. Hicks, C. M. Hollar, K. F. Ng-Kwai-
Hang, and H. E. Swaisgood. 2004. Nomenclature of the proteins of 
cows’ milk—Sixth revision. J. Dairy Sci. 87:1641–1674. https:// doi 
.org/ 10 .3168/ jds .S0022 -0302(04)73319 -6.
Formaggioni, P., A. Summer, M. Malacarne, and P. Mariani. 1999. 
Milk protein polymorphism: Detection and diffusion of the genetic 
variants in Bos genus. Ann. Fac. Med. Vet. Univ. Parma XIX: 
127–165.
Lebrun, I., F. L. Lebrun, O. B. Henriques, A. K. Carmona, L. Juliano, 
and A. C. Camargo. 1995. Isolation and characterization of a new 
bradykinin potentiating octapeptide from gamma-casein. Can. J. 
Physiol. Pharmacol. 73:85–91.
Plaisancié, P., R. Boutrou, M. Estienne, G. Henry, J. Jardin, A. Pa-
quet, and J. Léonil. 2015. β-Casein(94–123)-derived peptides dif-
ferently modulate production of mucins in intestinal goblet cells. J. 
Dairy Res. 82:36–46. https:// doi .org/ 10 .1017/ S0022029914000533.
Plaisancié, P., J. Claustre, M. Estienne, G. Henry, R. Boutrou, A. 
Paquet, and J. Léonil. 2013. A novel bioactive peptide from yo-
ghurts modulates expression of the gel-forming MUC2 mucin as 
well as population of goblet cells and Paneth cells along the small 
intestine. J. Nutr. Biochem. 24:213–221. https:// doi .org/ 10 .1016/ 
j .jnutbio .2012 .05 .004.
Senocq, D., D. Mollé, S. Pochet, J. Léonil, D. Dupont, and D. Levieux. 
2002. A new bovine β-casein genetic variant characterized by a 
Met93 > Leu93 substitution in the sequence A2. Lait 82:171–180.
Letter to the Editor: About bovine β-casofensin genetic 
variants—A comment on Bruno et al. (2017)
Stefania Chessa,*1 Omar Bulgari,† and Anna Maria Caroli†
*Istituto di Biologia e Biotecnologia Agraria, Consiglio Nazionale delle Ricerche, Lodi 26900, Italy
†Department of Molecular and Translational Medicine, University of Brescia, Brescia 25123, Italy
 
Received November 8, 2017.
Accepted December 26, 2017.
1 Corresponding author: chessa@ibba.cnr.it
